The data displays the leading cold, allergy, and sinus tablet vendors in the U.S. in 2016, based on sales. Reckitt Benckiser was ranked third with sales of 592.9 million USD. Total sales of U.S. cold, allergy, and sinus tablet vendors amounted to about 4.51 billion USD in 2016.
Private label | 1462.6 |
McNeil Con- sumer Healthcare |
609.8 |
Reckitt Benckiser | 592.9 |
MSD Consumer Care | 555.6 |
Chattem | 310.7 |
Bayer Healthcare | 224.6 |
Procter & Gamble | 203.6 |
Johnson & Johnson | 150.4 |
Pfizer | 114.9 |
Glaxosmithkline Consumer Healthcare | 81.6 |